Description of the event


AbbVie, Amgen, Merck, AstraZeneca, and more will present top case studies and new data in the following areas:

Day 1: Novel Protein Engineering & Designs
  • Applications of computational protein design and designing synthetic proteins
  • See success in the clinic of these complex molecules and lessons learned for R & D
  • Uncover creative engineering and design approaches for next generation protein therapeutics
Day 2: Overcoming Next Generation Protein Drug Challenges
  • Are you up-to-date on the use of novel protein therapeutics for diseases outside of oncology?
  • Overcome common protein drug challenges including efficacy, half-life and toxicity
  • NEW: Examining analytical strategies for characterization, developability and stability
Day 3: Targets, ADCs & Future Concepts
  • Discover the importance of identifying and utilizing new and more challenging targets
  • How can delivery methods enhance the effectiveness of these drugs and what new approaches are being used?
  • Share sessions with the bioconjugates audience to deliberate toxicity, stability and therapeutic window
  • Looking ahead: What will be the next successful molecule?


  • 22 June, 2020
  • until
  • 24 June, 2020


Hilton San Francisco Union Square, San Francisco, CA

Organised by

Meet experts attending at innovation events worldwide
Innoget is the most advanced innovation network to connect with decision makers attending top innovation events.

Free to join - no credit card required